Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Nimesh Jaiswal

Better Buy for 2022: Humana vs. Clover Health

With the increasing medical needs of an aging population, the health insurance industry is expected to keep growing. Moreover, the continued digitization and attractive insurance plans should contribute to the health insurance market’s growth in the near future. Therefore, both Humana (HUM) and Clover Health Investments (CLOV)  should benefit.

HUM operates as a health and well-being company. The company offers medical and supplemental benefit plans to individuals. CLOV operates as a medicare advantage insurer. Through its Clover Assistant, the company provides preferred provider organization and health maintenance organization, health plans for medicare-eligible consumers.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.